A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer.
一项针对转移性去势抵抗性前列腺癌患者的风险适应性策略的雄激素信号抑制剂组合模块化试验
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-23-3740
Aparicio Ana M, Tidwell Rebecca S S, Yadav Shalini S, Chen Jiun-Sheng, Zhang Miao, Liu Jingjing, Guo Shuai, Pilié Patrick G, Yu Yao, Song Xingzhi, Vundavilli Haswanth, Jindal Sonali, Zhu Keyi, Viscuse Paul V, Lebenthal Justin M, Hahn Andrew W, Soundararajan Rama, Corn Paul G, Zurita-Saavedra Amado, Subudhi Sumit K, Zhang Jianhua, Wang Wenyi, Huff Chad, Troncoso Patricia, Allison James P, Sharma Padmanee, Logothetis Christopher J
